importance of biomarkers when evaluating heterogeneity in her2 metastatic bc
Published 4 years ago • 41 plays • Length 10:07Download video MP4
Download video MP3
Similar videos
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
0:44
across-trop2: identifying predictive biomarkers of sg in hr /her2- breast cancer
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
6:15
beyond her2: dissecting tumor heterogeneity
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
6:45
innovative biomarker approaches in breast cancer therapy
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
1:55
predictive biomarkers in breast cancer
-
1:45
identifying novel predictive biomarkers in breast cancer
-
2:26
how biomarker testing can guide metastatic breast cancer treatment | jen heatherly
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
2:27
neoaltto: her2/cep17 ratio as a predictive biomarker in her breast cancer
-
1:00
the role of biomarkers in patients with breast cancer
-
1:39
dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
-
3:08
what biomarkers can tell you about your health!
-
1:03
elucidating immunotherapy biomarkers for breast cancer
-
57:52
biomarkers for treatment and progression | 2021-2022 embrace mbc virtual forum series
-
7:19
biomarkers for cdk4/6 inhibitors in hr mbc